beta-Blocker use following myocardial infarction: low prevalence of evidence-based dosing.
about
Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction.Beta-Blocker Therapy Early After Myocardial Infarction: A Comparison Between Medication at Hospital Discharge and Subsequent Pharmacy-Dispensed MedicationLink between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice.Mortality reduction with use of oral beta-blockers in patients with acute coronary syndromeAntianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease.Evaluation of medication compliance for secondary prevention of acute coronary syndrome.Heart rate control is associated with reduced cardiovascular events in Asian patients with coronary artery disease treated with bisoprolol (BISO-CAD): results from a multi-national, real-world experience.
P2860
Q36094414-B670B373-DA1A-45A3-B6C4-82B249D4C244Q37297906-BD50FC0F-7B20-407C-81F1-41B26AA45EAAQ37964807-ABFE4FCD-E349-4541-BE74-5BFE50824300Q39095735-826458BE-0813-4DD5-A858-AA960D9E9E83Q40406188-2AFC22B5-965D-455E-8458-441B0E18C0F2Q41656587-7B0272A1-D798-40BD-A95D-58036AEAB323Q53130477-1ECCB769-B135-4886-877D-3BE09049E6B9
P2860
beta-Blocker use following myocardial infarction: low prevalence of evidence-based dosing.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
beta-Blocker use following myo ...... ence of evidence-based dosing.
@ast
beta-Blocker use following myo ...... ence of evidence-based dosing.
@en
beta-Blocker use following myo ...... ence of evidence-based dosing.
@nl
type
label
beta-Blocker use following myo ...... ence of evidence-based dosing.
@ast
beta-Blocker use following myo ...... ence of evidence-based dosing.
@en
beta-Blocker use following myo ...... ence of evidence-based dosing.
@nl
prefLabel
beta-Blocker use following myo ...... ence of evidence-based dosing.
@ast
beta-Blocker use following myo ...... ence of evidence-based dosing.
@en
beta-Blocker use following myo ...... ence of evidence-based dosing.
@nl
P2093
P2860
P1476
beta-Blocker use following myo ...... ence of evidence-based dosing.
@en
P2093
Jeffrey J Goldberger
Michael Cuffe
PACE-MI Investigators
Prediman K Shah
Robert O Bonow
Robert O'Rourke
Yves Rosenberg
P2860
P304
435-442.e1
P356
10.1016/J.AHJ.2010.06.023
P407
P577
2010-09-01T00:00:00Z